TGA Requests Public Input on E-Cigarette Regulation Reform

Dec.01.2022
TGA Requests Public Input on E-Cigarette Regulation Reform
Australia's TGA seeks public input on e-cigarette regulation reform to prevent youth access and promote doctor-prescribed quitting aids.

On November 30, 2022, the Australian Therapeutic Goods Administration (TGA) published an article on its official website, inviting the general public to provide suggestions and recommendations on reforming e-cigarette regulations.


According to an article by TGA:


This potential regulatory reform aims to prevent minors and children from being exposed to nicotine-containing e-cigarette products, while also supporting "known ingredient, high-quality" e-cigarettes as a prescription tool for doctors to help adult smokers quit.


On January 1st, 2021, the Australian government reformed its regulation of electronic cigarettes, reclassifying nicotine-containing e-cigarettes as prescription drugs. However, more than a year after the reform was implemented, a significant number of young children continue to use e-cigarettes, and many adults are purchasing them through the black market rather than obtaining them through registered Australian physicians' prescriptions.


Australia's Therapeutic Goods Administration (TGA) has invited public feedback on proposed reforms in four areas. These include easing border controls on nicotine e-cigarettes to curb black market supply, assessing pre-market for quality assurance, encouraging doctors to prescribe and pharmacies to supply regulated e-cigarette products, strengthening minimum quality and safety standards, and treating nicotine e-cigarettes as medicinal products to ensure effective regulation. The public consultation period will run until January 16, 2023, and interested parties can submit feedback through TGA's consultation center. After analyzing the feedback, the TGA will initiate any reforms in discussion with the government. There will be a transition period before the regulatory changes take effect.


Australia's stringent regulation of electronic cigarettes has led to a booming illegal market. According to The Australian newspaper, as of October 2022, the adult usage rate of e-cigarettes in Australia is 5.8%, with 88% of these users purchasing e-cigarettes through illegal channels. In the past five years, the number of e-cigarette users has skyrocketed by 259%.


2FIRSTS will continue to report on this topic, with further updates available on the "2FIRSTS APP". Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore will maintain etomidate’s classification under drug control laws while preparing new legislation targeting e-vaporisers, as authorities reinforce a hardline regulatory stance on vaping.
Feb.05
Heated tobacco brand DIITO launches in Mongolia
Heated tobacco brand DIITO launches in Mongolia
A new heat-not-burn (HNB) brand, DIITO, has commenced promotional activities in the Mongolian market. The device features an integrated display panel and supports dual heating modes, "RELAX" and "RUSH." Investigations reveal that DIITO’s local promotion closely overlaps with RELX’s official distribution channels. Furthermore, the DIITO trademark is held by the UK-based REAZEN TECH LIMITED, a company that also manages the e-cigarette brand FASTA.
Jan.16 by 2FIRSTS.ai
Kentucky to issue provisional state licenses to tobacco, nicotine and vapor retailers who applied before Jan. 1, 2026
Kentucky to issue provisional state licenses to tobacco, nicotine and vapor retailers who applied before Jan. 1, 2026
Kentucky will issue provisional state licenses to tobacco, nicotine and vapor product retailers that applied for a license with the Department of Alcoholic Beverage Control (ABC) before Jan. 1, 2026.
Dec.31 by 2FIRSTS.ai
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11
British American Tobacco to close South Africa cigarette plant by end-2026, citing illicit trade squeezing legal market
British American Tobacco to close South Africa cigarette plant by end-2026, citing illicit trade squeezing legal market
British American Tobacco South Africa (BATSA) said it will halt local production of factory-made cigarettes and close its manufacturing plant in Heidelberg, Gauteng by the end of 2026, shifting to an import-led supply model. The company said illicit cigarettes now account for about 75% of South Africa’s market, making local manufacturing “unsustainable” and putting around 230 jobs at risk.
Jan.16
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
After France’s ANSES report on nicotine products and harm reduction, Dr. Xin-an Liu wrote to 2Firsts reassessing the field’s foundations. She argues the debate reveals gaps in evidence on long-term behavioral substitution, addiction pathways and neurobiological impacts, and calls for longitudinal research, integrated behavioral science and neuroimaging, clearer risk assessment and stronger transparency to ensure policy and next-generation product development rest on solid evidence.
Industry Insight
Feb.24